Incisors Single-Unit Rehabilitation With Narrow GM Implants
Launched by NEODENT · Feb 18, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a type of dental implant called Narrow GM Implants, which are designed to help people who have lost teeth in the front part of their mouth. The goal of the study is to see how safe and effective these implants are for patients over a period of three years. The trial will involve 55 participants who need at least one implant in the area of their lateral incisors (the teeth next to the front teeth). Participants will be closely monitored for any problems or side effects during the study.
To be eligible for this trial, participants must be at least 18 years old and have missing teeth in the specified regions of their mouth, but they should also have natural teeth nearby. Certain health issues or conditions, like severe gum disease, uncontrolled diabetes, or allergies to titanium, may prevent someone from participating. Those who join the study can expect to receive routine care with the implants and will be followed up to ensure their safety and the success of the treatment. This study is important as it aims to provide valuable information that can help improve dental care for patients needing implants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with 18 years of age or more
- • At least one edentulous site in the region of lateral incisors in the maxilla and/or lateral and central incisors in the mandible
- • Presence of natural adjacent and opposing tooth,
- • Qualified for rehabilitation with narrow implants and single-unit fixed prostheses.
- Exclusion Criteria:
- As exclusion criteria, the contraindications, and warnings according to the Instructions for Use of the device will be applied, as follows:
- • Signs of allergy or hypersensitivity to titanium
- • Periodontal disease
- • heavy smoking/alcohol drinking habits
- • bruxism
- • high use of bisphosphonate drugs or proton pump inhibitors (PPIs)
- • radiation therapy
- • diabetes
- • autoimmune diseases
- • uncontrolled systemic complications or diseases
- • incomplete jawbone growth
- • bleeding disorders
- • HIV
- • osteoporosis
- • pregnancy.
About Neodent
Neodent, a leading global provider of dental implants and solutions, specializes in innovative technologies and products that enhance dental restoration and rehabilitation. With a commitment to advancing oral healthcare, Neodent invests in research and development, ensuring that its clinical trials adhere to the highest standards of safety and efficacy. The company collaborates with dental professionals and institutions worldwide to explore new methodologies and improve patient outcomes, positioning itself at the forefront of dental innovation and excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Goiânia, Goiás, Brazil
Uberlândia, Minas Gerais, Brazil
Goiânia, , Brazil
Patients applied
Trial Officials
Waleska C Furquim, PhD
Study Director
Neodent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials